INVITAE CORP's ticker is NVTA and the CUSIP is 46185L103. A total of 219 filers reported holding INVITAE CORP in Q3 2023. The put-call ratio across all filers is 2.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $400,000 | -13.8% | 162,400 | -14.5% | 0.02% | -9.5% |
| Q2 2022 | $464,000 | -59.3% | 190,000 | +32.9% | 0.02% | -50.0% |
| Q1 2022 | $1,140,000 | -47.8% | 143,000 | 0.0% | 0.04% | -45.5% |
| Q4 2021 | $2,184,000 | -46.3% | 143,000 | 0.0% | 0.08% | -51.6% |
| Q3 2021 | $4,065,000 | +7.6% | 143,000 | +27.7% | 0.16% | +11.2% |
| Q2 2021 | $3,778,000 | +4.1% | 112,000 | +17.9% | 0.14% | +13.5% |
| Q1 2021 | $3,630,000 | -8.6% | 95,000 | 0.0% | 0.13% | -29.2% |
| Q4 2020 | $3,972,000 | -22.8% | 95,000 | -20.0% | 0.18% | -16.4% |
| Q3 2020 | $5,146,000 | +24.5% | 118,706 | -13.0% | 0.21% | -6.6% |
| Q2 2020 | $4,134,000 | +314.2% | 136,491 | +87.0% | 0.23% | +216.7% |
| Q1 2020 | $998,000 | -6.3% | 73,000 | +10.6% | 0.07% | +22.0% |
| Q4 2019 | $1,065,000 | +20.2% | 66,000 | +43.5% | 0.06% | +13.5% |
| Q3 2019 | $886,000 | -18.0% | 46,000 | 0.0% | 0.05% | -16.1% |
| Q2 2019 | $1,081,000 | -97.6% | 46,000 | +4171.1% | 0.06% | -65.7% |
| Q1 2019 | $46,000,000 | +8937.3% | 1,077 | -97.7% | 0.18% | +417.1% |
| Q4 2018 | $509,000 | -33.9% | 46,000 | 0.0% | 0.04% | -20.5% |
| Q3 2018 | $770,000 | +127.8% | 46,000 | 0.0% | 0.04% | +109.5% |
| Q2 2018 | $338,000 | – | 46,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMORY UNIVERSITY | 173,743 | $1,254,000 | 3.49% |
| Camber Capital Management LP | 894,014 | $6,455,000 | 0.55% |
| Baker Brothers Advisors | 6,554,967 | $47,327,000 | 0.44% |
| Redmile Group, LLC | 660,129 | $4,766,000 | 0.36% |
| Rock Springs Capital Management LP | 510,000 | $3,682,000 | 0.30% |
| Verity Asset Management, Inc. | 16,922 | $122,000 | 0.12% |
| Perceptive Advisors | 336,666 | $2,431,000 | 0.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 166,666 | $1,203,000 | 0.05% |
| Orbimed Advisors | 456,666 | $3,297,000 | 0.03% |
| TFS CAPITAL LLC | 34,044 | $246,000 | 0.02% |